Proc Natl Acad Sci USA 108:1639816403 Lepore AC, Rauck B, Deje C et al (2008) Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease
Studies show antioxidant support during GLP-1 therapy improves symptom tolerance, though glutathione alone doesn't eliminate side effectsproper timing and dose escalation of semaglutide do

A number of studies support NAD + regeneration as a therapeutic strategy to benefit patients with obesity.[27] For examples, natural NAD + precursor activators such as nicotinamide riboside (NR) administered via dietary supplements to high-fat fed mice protected against diet-induced obesity, increased energy metabolism, and improved insulin sensitivity;[41] some of these effects were shown to be mediated by NAD + -dependent SIRT1 activation.[42] Similarly, systemic administration of NMN improved glucose tolerance and diet- and age-related insulin resistant conditions.[43, 44] However, dietary supplemental NAD + precursors (e.g., NR, NMN) require chronic administration and/or very high pharmacological doses to achieve physiologically beneficial enhancements in the NAD + levels, which potentially limit use in humans.[27] It could be predicted that combined administration of sub-maximal doses of dietary supplements and NNMT inhibitors that function as activators of NAD + might produce synergistic improvements in diet-induced obesity, and reduce adverse effects associated with chronic high-dose administration of dietary supplemental NAD + precursors

We aim to provide access to quality private healthcare services locally